ダウンロード数: 8707
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 57_209.pdf | 1.25 MB | Adobe PDF | 見る/開く |
| タイトル: | 集学的治療が奏効した進行前立腺導管癌の2例 |
| その他のタイトル: | Successful Combined Treatment with Maximal Androgen Blockade (MAB), Intra Arterial Chemotherapy and Radiation for Advanced Prostatic Ductal Adenocarcinoma : Report of Two Cases |
| 著者: | 西原, 千香子  鞍作, 克之 田中, 智章 川嶋, 秀紀 仲谷, 達也 |
| 著者名の別形: | Nishihara, Chikako Kuratsukuri, Katsuyuki Tanaka, Tomoaki Kawashima, Hidenori Nakatani, Tatsuya |
| キーワード: | Prostatic ductal adenocarcinoma Chemotherapy |
| 発行日: | Apr-2011 |
| 出版者: | 泌尿器科紀要刊行会 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 57 |
| 号: | 4 |
| 開始ページ: | 209 |
| 終了ページ: | 212 |
| 抄録: | The first case was in a 73-year-old man with macrohematuria. The second case was in a 59-year-old man with pollakiuria. Their serum prostate specific antigen levels were slightly elevated and urinary cytology was negative. Histological examination by prostatic needle biopsy and biopsy from bladder neck showed prostatic ductal adenocarcinoma. Clinical stage on computed tomography and magnetic resonance imaging was T4N0M0 in both cases. After 10-month maximal androgen blockade(MAB) and arterial cemotherapy using reservoir system, radiation therapy was performed. After that, low dose FP-chemotherapy (5-fluorouracil 600 mg/day，cisplatinum 10 mg/day) was performed for 28 days in the first case. At present, there are no signs of recurrence or metastasis in either case. |
| 著作権等: | 許諾条件により本文は2012-05-01に公開 |
| URI: | http://hdl.handle.net/2433/141821 |
| PubMed ID: | 21646853 |
| 出現コレクション: | Vol.57 No.4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。